Additionally, in comparison to the patient cohort suffering from newly diagnosed glioblastomas and being treated with chemoradiation as reported by Hegi et al. [56] (see Table 6), the iPDT cohort reported here showed superior survival both for methylated and unmethylated MGMT promoters. The gene discussed is MGMT; the disease is glioblastoma.